Arianna L. Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Arianna L. Kim has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Athar
Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
6 shared publicationsYucui Zhu
Department of Dermatology, Columbia University Medical Center, New York, New York, United States of America
6 shared publicationsJung Ho Back
Department of Dermatology, Columbia University Medical Center, New York, New York, United States of America
4 shared publicationsDavid R. Bickers
Department of Dermatology, Columbia University Medical Center, Irving Cancer Research Center, New York, NY 10032
3 shared publicationsLevy Kopelovich
Division of Cancer Chemoprevention, Department of Dermatology, National Cancer Institute, Bethesda, Maryland, USA
3 shared publications- Hamid Reza Rezvani
Univ. Bordeaux, Inserm, BRIC, UMR 1312, F-33076 Bordeaux, France
2 shared publications
Latest Publications
- Open Access
- 13 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e97245
Inhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation
P38 mitogen-activated protein kinases (MAPKs) respond to a wide range of extracellular stimuli. While the inhibition of p38 signaling is implicated in the impaired capacity to repair ultraviolet (UV)-induced DNA damage—a primary risk factor for human skin cancers—its mechanism of action in skin carcinogenesis remains unclear, as both anti-proliferative and survival functions have been previously described. In this study, we utilized cultured keratinocytes, murine tumorigenesis models, and human cutaneous squamous cell carcinoma (SCC) specimens to assess the effect of p38 in this regard. UV irradiation of normal human keratinocytes increased the expression of all four p38 isoforms (α/β/γ/δ); whereas irradiation of p53-deficient A431 keratinocytes derived from a human SCC selectively decreased p38α, without affecting other isoforms. p38α levels are decreased in the majority of human cutaneous SCCs assessed by tissue microarray, suggesting a tumor-suppressive effect of p38α in SCC pathogenesis. Genetic and pharmacological inhibition of p38α and in A431 cells increased cell proliferation, which was in turn associated with increases in NAPDH oxidase (NOX2) activity as well as intracellular reactive oxygen species (ROS). These changes led to enhanced invasiveness of A431 cells as assessed by the matrigel invasion assay. Chronic treatment of p53-/-/SKH-1 mice with the p38 inhibitor SB203580 accelerated UV-induced SCC carcinogenesis and increased the expression of NOX2. NOX2 knockdown suppressed the augmented growth of A431 xenografts treated with SB203580. These findings indicate that in the absence of p53, p38α deficiency drives SCC growth and progression that is associated with enhanced NOX2 expression and ROS formation.
- 13 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e97245
Open AccessInhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation
P38 mitogen-activated protein kinases (MAPKs) respond to a wide range of extracellular stimuli. While the inhibition of p38 signaling is implicated in the impaired capacity to repair ultraviolet (UV)-induced DNA damage—a primary risk factor for human skin cancers—its mechanism of action in skin carcinogenesis remains unclear, as both anti-proliferative and survival functions have been previously described. In this study, we utilized cultured keratinocytes, murine tumorigenesis models, and human cutaneous squamous cell carcinoma (SCC) specimens to assess the effect of p38 in this regard. UV irradiation of normal human keratinocytes increased the expression of all four p38 isoforms (α/β/γ/δ); whereas irradiation of p53-deficient A431 keratinocytes derived from a human SCC selectively decreased p38α, without affecting other isoforms. p38α levels are decreased in the majority of human cutaneous SCCs assessed by tissue microarray, suggesting a tumor-suppressive effect of p38α in SCC pathogenesis. Genetic and pharmacological inhibition of p38α and in A431 cells increased cell proliferation, which was in turn associated with increases in NAPDH oxidase (NOX2) activity as well as intracellular reactive oxygen species (ROS). These changes led to enhanced invasiveness of A431 cells as assessed by the matrigel invasion assay. Chronic treatment of p53-/-/SKH-1 mice with the p38 inhibitor SB203580 accelerated UV-induced SCC carcinogenesis and increased the expression of NOX2. NOX2 knockdown suppressed the augmented growth of A431 xenografts treated with SB203580. These findings indicate that in the absence of p53, p38α deficiency drives SCC growth and progression that is associated with enhanced NOX2 expression and ROS formation.
- 24 January 2012
- Published by Wiley in Photochemistry and Photobiology
- Vol. 88 (5) , 1165-1172
Resveratrol‐Mediated Downregulation of Rictor Attenuates Autophagic Process and Suppresses UV‐Induced Skin Carcinogenesis†
Macroautophagy is a cellular response to various environmental stresses that ensures lysosomal degradation of long‐lived and damaged proteins and cellular organelles. It occurs through the formation of an autophagosome, which then fuses with a lysosome to form an autolysosome. Depending on the cellular context, autophagy may promote cancer cell survival or it may serve as a mechanism of tumor suppression. Herein, we show that resveratrol, a natural phytoalexin, induces premature senescence in human A431 SCC cells, and that resveratrol‐induced premature senescence is associated with a blockade of autolysosome formation, as assessed by the absence of colocalization of LC3 and Lamp‐2, markers for autophagosomes and lysosomes, respectively. Further, we show that resveratrol downregulates the level of Rictor, a component of mTORC2, leading to decreased RhoA‐GTPase and altered actin cytoskeleton organization. Exogenous overexpression of Rictor restores RhoA‐GTPase activity and actin cytoskeleton network, and decreases resveratrol‐induced senescence‐associated β‐gal activity, indicating a direct role of Rictor in senescence induction. Rictor is overexpressed in UV‐induced murine SCCs, whereas its expression is diminished by oral administration of resveratrol. These data indicate that resveratrol attenuates autophagic process via Rictor, and suggest that downregulation of Rictor may be a mechanism of tumor suppression associated with premature senescence.
- 24 January 2012
- Published by Wiley in Photochemistry and Photobiology
- Vol. 88 (5) , 1165-1172
Resveratrol‐Mediated Downregulation of Rictor Attenuates Autophagic Process and Suppresses UV‐Induced Skin Carcinogenesis†
Macroautophagy is a cellular response to various environmental stresses that ensures lysosomal degradation of long‐lived and damaged proteins and cellular organelles. It occurs through the formation of an autophagosome, which then fuses with a lysosome to form an autolysosome. Depending on the cellular context, autophagy may promote cancer cell survival or it may serve as a mechanism of tumor suppression. Herein, we show that resveratrol, a natural phytoalexin, induces premature senescence in human A431 SCC cells, and that resveratrol‐induced premature senescence is associated with a blockade of autolysosome formation, as assessed by the absence of colocalization of LC3 and Lamp‐2, markers for autophagosomes and lysosomes, respectively. Further, we show that resveratrol downregulates the level of Rictor, a component of mTORC2, leading to decreased RhoA‐GTPase and altered actin cytoskeleton organization. Exogenous overexpression of Rictor restores RhoA‐GTPase activity and actin cytoskeleton network, and decreases resveratrol‐induced senescence‐associated β‐gal activity, indicating a direct role of Rictor in senescence induction. Rictor is overexpressed in UV‐induced murine SCCs, whereas its expression is diminished by oral administration of resveratrol. These data indicate that resveratrol attenuates autophagic process via Rictor, and suggest that downregulation of Rictor may be a mechanism of tumor suppression associated with premature senescence.
- 15 November 2011
- Published by Taylor & Francis in Cell Cycle
- Vol. 10 (22) , 3849-3852
The expanding relevance of nuclear mTOR in carcinogenesis
Deregulated mTOR signaling drives the growth of various human cancers, making mTOR a major target for development of cancer chemotherapeutics. The role of mTOR in carcinogenesis is thought to be largely a consequence of its activity in the cytoplasm resulting in increased translation of pro-tumorigenic genes. However, emerging data locate mTOR in various subcellular compartments including Golgi, mitochondria, endoplasmic reticulum, and the nucleus, implying the presence of compartment-specific mTOR substrates and functions. Efforts to identify mTOR substrates in these compartments, and the mechanisms by which mTOR recruits these substrates and affects downstream cellular processes, will add to our understanding of the diversity of roles played by mTOR in carcinogenesis.
- 15 November 2011
- Published by Taylor & Francis in Cell Cycle
- Vol. 10 (22) , 3849-3852
The expanding relevance of nuclear mTOR in carcinogenesis
Deregulated mTOR signaling drives the growth of various human cancers, making mTOR a major target for development of cancer chemotherapeutics. The role of mTOR in carcinogenesis is thought to be largely a consequence of its activity in the cytoplasm resulting in increased translation of pro-tumorigenic genes. However, emerging data locate mTOR in various subcellular compartments including Golgi, mitochondria, endoplasmic reticulum, and the nucleus, implying the presence of compartment-specific mTOR substrates and functions. Efforts to identify mTOR substrates in these compartments, and the mechanisms by which mTOR recruits these substrates and affects downstream cellular processes, will add to our understanding of the diversity of roles played by mTOR in carcinogenesis.
- Open Access
- 1 May 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (21) , 19100-19108
Cancer Cell Survival Following DNA Damage-mediated Premature Senescence Is Regulated by Mammalian Target of Rapamycin (mTOR)-dependent Inhibition of Sirtuin 1
- 1 May 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (21) , 19100-19108
Open AccessCancer Cell Survival Following DNA Damage-mediated Premature Senescence Is Regulated by Mammalian Target of Rapamycin (mTOR)-dependent Inhibition of Sirtuin 1
- 1 January 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (1) , 195-202
Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression
- 1 January 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (1) , 195-202
Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression
- 1 June 2009
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 486 (2) , 95-102
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
- 1 June 2009
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 486 (2) , 95-102
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
- 2 June 2006
- Published by Wiley in Experimental Dermatology
- Vol. 15 (7) , 538-546
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways
Abstract: Resveratrol (trans‐3,4′,5‐trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin found in grapes, and has been shown to inhibit the growth of various types of cancer cells. We investigated the mechanism of the antiproliferative effect of resveratrol in A431‐transformed keratinocytes harbouring mutant p53, and show that it is accompanied by G1 cell cycle arrest, which coincides with a marked inhibition of G1 cell cycle regulatory proteins, including cyclins A and D1 and cyclin‐dependent kinase (CDK)6 and p53‐independent induction of p21WAF1. Cell cycle arrest was also associated with the accumulation of hypophosphorylated Rb and p27KIP1. Resveratrol inhibited mitogen‐activated protein kinase/extracellular signal‐regulated kinase kinase (MEK)1 > extracellular signal‐regulated protein kinase (ERK)1/2 signalling, downregulated c‐Jun, and suppressed activating protein (AP)‐1 DNA‐binding and promoter activity. In addition, the inhibition of MEK1 > ERK1/2 signalling appears to be independent of retinoblastoma protein (pRb) hypophosphorylation in A431 cells, as PD098059 did not suppress pRb phosphorylation. Our results demonstrate that resveratrol affects multiple cellular targets in A431 cells, and that the downregulation of both AP‐1 and pRb contributes to its antiproliferative activity in these cells.
- 2 June 2006
- Published by Wiley in Experimental Dermatology
- Vol. 15 (7) , 538-546
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP‐1 signalling pathways
Abstract: Resveratrol (trans‐3,4′,5‐trihydroxystilbene) is a naturally occurring polyphenolic phytoalexin found in grapes, and has been shown to inhibit the growth of various types of cancer cells. We investigated the mechanism of the antiproliferative effect of resveratrol in A431‐transformed keratinocytes harbouring mutant p53, and show that it is accompanied by G1 cell cycle arrest, which coincides with a marked inhibition of G1 cell cycle regulatory proteins, including cyclins A and D1 and cyclin‐dependent kinase (CDK)6 and p53‐independent induction of p21WAF1. Cell cycle arrest was also associated with the accumulation of hypophosphorylated Rb and p27KIP1. Resveratrol inhibited mitogen‐activated protein kinase/extracellular signal‐regulated kinase kinase (MEK)1 > extracellular signal‐regulated protein kinase (ERK)1/2 signalling, downregulated c‐Jun, and suppressed activating protein (AP)‐1 DNA‐binding and promoter activity. In addition, the inhibition of MEK1 > ERK1/2 signalling appears to be independent of retinoblastoma protein (pRb) hypophosphorylation in A431 cells, as PD098059 did not suppress pRb phosphorylation. Our results demonstrate that resveratrol affects multiple cellular targets in A431 cells, and that the downregulation of both AP‐1 and pRb contributes to its antiproliferative activity in these cells.
- 1 June 2005
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (6) , 1318-1325
Role of p38 MAPK in UVB-Induced Inflammatory Responses in the Skin of SKH-1 Hairless Mice
- 1 June 2005
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (6) , 1318-1325
Role of p38 MAPK in UVB-Induced Inflammatory Responses in the Skin of SKH-1 Hairless Mice